WallStreetZenWallStreetZen

NASDAQ: FGEN
Fibrogen Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

FGEN past revenue growth

How has FGEN's revenue growth performed historically?
Company
4.99%
Industry
144.63%
Market
17.55%
FGEN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
FGEN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
FGEN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

FGEN earnings and revenue history

Current Revenue
$147.8M
Current Earnings
-$284.2M
Current Profit Margin
-192.4%

FGEN Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when FGEN announces earnings.

FGEN Return on Assets

Current Company
-58.7%
Current Industry
2.9%
FGEN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

FGEN Return on Capital Employed

Current Company
-130.52%
Current Industry
19.5%
FGEN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

FGEN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
FGEN$147.75M-$258.77M-$284.23M-7.05%N/A
ANIX$210.00k-$10.70M-$10.74M-28.36%N/A
BLUE$21.73M-$95.08M-$91.17M-11.27%N/A
CLSD$8.23M-$32.42M-$32.49M+207.34%N/A
RZLT$0.00-$56.28M-$56.83MN/AN/A
View Top Biotech Stocks

FGEN earnings dates

Next earnings date
Jun 5, 2024

Fibrogen Earnings & Revenue FAQ

What were FGEN's earnings last quarter?

On Invalid Date, Fibrogen (NASDAQ: FGEN) reported Q4 2023 earnings per share (EPS) of -$0.57, up 19.72% year over year. Total Fibrogen earnings for the quarter were -$56.23 million. In the same quarter last year, Fibrogen's earnings per share (EPS) was -$0.71.

If you're new to stock investing, here's how to buy Fibrogen stock.

What was FGEN's earnings growth in the past year?

As of Q2 2024, Fibrogen's earnings has grown year over year. Fibrogen's earnings in the past year totalled -$284.23 million.

What is FGEN's earnings date?

Fibrogen's earnings date is Invalid Date. Add FGEN to your watchlist to be reminded of FGEN's next earnings announcement.

What was FGEN's revenue last quarter?

On Invalid Date, Fibrogen (NASDAQ: FGEN) reported Q4 2023 revenue of $27.14 million up 21.03% year over year. In the same quarter last year, Fibrogen's revenue was $34.37 million.

What was FGEN's revenue growth in the past year?

As of Q2 2024, Fibrogen's revenue has grown 4.99% year over year. This is 139.64 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Fibrogen's revenue in the past year totalled $147.75 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.